iRhoms: A Potential Path to More Specific Therapeutic Targeting of Lupus Nephritis
- PMID: 29887489
- DOI: 10.1053/j.ajkd.2018.04.010
iRhoms: A Potential Path to More Specific Therapeutic Targeting of Lupus Nephritis
Comment on
-
iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.J Clin Invest. 2018 Apr 2;128(4):1397-1412. doi: 10.1172/JCI97650. Epub 2018 Mar 5. J Clin Invest. 2018. PMID: 29369823 Free PMC article.
Similar articles
-
Spontaneous resolution of lupus nephritis following withdrawal of etanercept.Ann Clin Lab Sci. 2013 Fall;43(4):447-9. Ann Clin Lab Sci. 2013. PMID: 24247804
-
Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.Lupus. 2018 Feb;27(2):243-256. doi: 10.1177/0961203317717083. Epub 2017 Jun 28. Lupus. 2018. PMID: 28659046
-
Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis.Nephrology (Carlton). 2017 Feb;22(2):101-106. doi: 10.1111/nep.12957. Nephrology (Carlton). 2017. PMID: 27786399 Review.
-
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.Arthritis Rheumatol. 2014 Mar;66(3):674-85. doi: 10.1002/art.38259. Arthritis Rheumatol. 2014. PMID: 24574228
-
Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.Semin Nephrol. 2007 Jan;27(1):81-97. doi: 10.1016/j.semnephrol.2006.09.010. Semin Nephrol. 2007. PMID: 17336691 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous